2-羰基-3-苯基丙酸芳甲酰腙二(2,4-二氯苄基)锡配合物的合成、晶体结构及生物活性

二（2,4-二氯苄基）二氯化锡分别与2-羰基-3-苯基丙酸苯甲酰腙及2-羰基-3-苯基丙酸水杨酰腙反应,合成了2个取代苄基锡配合物（C1、C2）,通过元素分析、IR、¹H NMR、¹³C NMR、¹¹⁹Sn NMR、X射线单晶衍射以及热重分析等表征了配合物结构。测试了配合物对癌细胞Hela、MCF7、HepG2、Colo205、NCI-H460以及正常人体胚肾细胞HEK293、正常人体肝细胞HL7702的体外抑制活性;在Tris-HCl缓冲溶液中,以EB做为荧光探针,用荧光光谱法初步研究了配合物与小牛胸腺DNA的相互作用。结果表明：配合物C1、C2对5种癌细胞都有明显的抑制作用,配合物C2对HEK293、HL7702的细胞毒性远小于C1;配合物C1与小牛胸腺DNA作用是插入结合与静电结合共同作用所致,配合物C2与小牛胸腺DNA作用是插入结合作用所致。     

2-羰基-3-苯基丙酸芳甲酰腙二(2,4-二氯苄基)锡配合物的合成、晶体结构及生物活性

二(2,4-二氯苄基)二氯化锡分别与2-羰基-3-苯基丙酸苯甲酰腙及2-羰基-3-苯基丙酸水杨酰腙反应,合成了2个取代苄基锡配合物(C1、C2),通过元素分析、IR、1H NMR、13C NMR、119Sn NMR、X射线单晶衍射以及热重分析等表征了配合物结构。测试了配合物对癌细胞Hela、MCF7、Hep G2、Colo205、NCI-H460以及正常人体胚肾细胞HEK293、正常人体肝细胞HL7702的体外抑制活性;在Tris-HCl缓冲溶液中,以EB做为荧光探针,用荧光光谱法初步研究了配合物与小牛胸腺DNA的相互作用。结果表明:配合物C1、C2对5种癌细胞都有明显的抑制作用,配合物C2对HEK293、HL7702的细胞毒性远小于C1;配合物C1与小牛胸腺DNA作用是插入结合与静电结合共同作用所致,配合物C2与小牛胸腺DNA作用是插入结合作用所致。     

N-(2-丙酸)-芳甲酰腙二对甲基苄基锡配合物的合成、晶体结构及生物活性

二对甲基苄基二氯化锡分别与N-(2-丙酸)-对硝基苯甲酰腙及N-(2-丙酸)-对叔丁基苯甲酰腙反应,合成了2个取代二苄基锡配合物(C1、C2),通过元素分析、IR、UV-Vis、1H NMR、13C NMR、119Sn NMR、X射线单晶衍射以及热重分析等表征了配合物结构。测试了配合物对癌细胞H460、HepG2、MCF7以及正常人体肝细胞HL7702的体外抑制活性;在Tris-HCl缓冲溶液中,以EB作为荧光探针,用荧光光谱法初步研究了配合物与小牛胸腺DNA的相互作用。结果表明:配合物C1、C2对3种癌细胞都有较好的抑制作用,配合物C2对HL7702的细胞毒性远小于C1;配合物C1、C2与小牛胸腺DNA作用均是插入结合作用所致。     

N-(2-丙酸)-芳甲酰腙二对甲基苄基锡配合物的合成、晶体结构及生物活性

二对甲基苄基二氯化锡分别与N-（2-丙酸）-对硝基苯甲酰腙及N-（2-丙酸）-对叔丁基苯甲酰腙反应,合成了2个取代二苄基锡配合物（C1、C2）,通过元素分析、IR、UV-Vis、¹H NMR、¹³C NMR、¹¹⁹Sn NMR、X射线单晶衍射以及热重分析等表征了配合物结构。测试了配合物对癌细胞H460、HepG2、MCF7以及正常人体肝细胞HL7702的体外抑制活性;在Tris-HCl缓冲溶液中,以EB作为荧光探针,用荧光光谱法初步研究了配合物与小牛胸腺DNA的相互作用。结果表明：配合物C1、C2对3种癌细胞都有较好的抑制作用,配合物C2对HL7702的细胞毒性远小于C1;配合物C1、C2与小牛胸腺DNA作用均是插入结合作用所致。     

2-羰基丙酸芳甲酰腙二对甲基苄基锡配合物的合成、晶体结构及生物活性

在含水甲苯中,对甲基氯苄与锡粉反应合成了二对甲基苄基二氯化锡,将其分别与2-羰基丙酸苯甲酰腙及2-羰基丙酸水杨酰腙反应,合成了2个取代苄基锡配合物(1、2),通过元素分析、IR、1H NMR、13C NMR、X射线单晶衍射以及热重分析等表征了配合物结构。测试了配合物对癌细胞MCF-7、Hep G2、NCI-H460以及正常人体肝细胞HL-7702的体外抑制活性;在Tris-HCl缓冲溶液中,以EB作为荧光探针,用荧光光谱法初步研究了配合物与小牛胸腺DNA的相互作用。结果表明:配合物1、2对3种癌细胞都有明显的抑制作用,配合物2对HL-7702的细胞毒性小于1;配合物1与小牛胸腺DNA作用是插入结合与静电结合共同作用所致,配合物2与小牛胸腺DNA作用是插入结合作用所致。     

2-羰基丙酸芳甲酰腙二对甲基苄基锡配合物的合成、晶体结构及生物活性

在含水甲苯中,对甲基氯苄与锡粉反应合成了二对甲基苄基二氯化锡,将其分别与2-羰基丙酸苯甲酰腙及2-羰基丙酸水杨酰腙反应,合成了2个取代苄基锡配合物（1、2）,通过元素分析、IR、¹H NMR、¹³C NMR、X射线单晶衍射以及热重分析等表征了配合物结构。测试了配合物对癌细胞MCF-7、HepG2、NCI-H460以及正常人体肝细胞HL-7702的体外抑制活性;在Tris-HCl缓冲溶液中,以EB作为荧光探针,用荧光光谱法初步研究了配合物与小牛胸腺DNA的相互作用。结果表明：配合物1、2对3种癌细胞都有明显的抑制作用,配合物2对HL-7702的细胞毒性小于1;配合物1与小牛胸腺DNA作用是插入结合与静电结合共同作用所致,配合物2与小牛胸腺DNA作用是插入结合作用所致。     

二对甲基苄基锡芳甲酰腙配合物的合成、晶体结构及生物活性

将二对甲基苄基二氯化锡分别与2-[(4-硝基-苯甲酰基)-亚肼基]-3-苯基-丙酸或2-[(噻吩-2-羰基)-亚肼基]-3-苯基-丙酸反应,合成了2个以Sn_2O_2四元环为中心对称的二对甲基苄基锡配合物(C1、C2),通过元素分析、IR、~1H NMR、~(13)C NMR、~(119)Sn NMR、HRMS以及X-射线单晶衍射等表征了配合物的结构。测试了配合物C1、C2对癌细胞NCI-H460、HepG2、MCF7的体外抑制活性,结果表明,配合物C1、C2对3种癌细胞都有较好的抑制作用,C1略优于C2。通过紫外光谱、荧光光谱、粘度法测试配合物C1与小牛胸腺DNA的相互作用方式,结果均显示配合物C1与小牛胸腺DNA的作用是插入结合,并且作用效果较强;凝胶电泳研究表明,配合物C1能够有效地将超螺旋DNA pBR322切割成缺刻型DNA。     

基于取代苯甲酰肼缩丙酮酸配体的二苄基锡配合物的合成、晶体结构及生物活性

二苄基二氯化锡分别与对甲氧基苯甲酰肼缩丙酮酸及对硝基苯甲酰肼缩丙酮酸反应,合成了2个二苄基锡配合物(C1、C2),通过元素分析、IR、~1H NMR、~(13)C NMR、~(119)Sn NMR、HRMS以及X射线单晶衍射等表征了配合物结构。测试了配合物C1、C2的热稳定性以及配合物对癌细胞H460、HepG2、MCF7的体外抑制活性;在Tris-HCl缓冲溶液中,以EB做为荧光探针,用荧光光谱法初步研究了配合物C1与小牛胸腺DNA的相互作用;并且用凝胶电泳法研究了配合物C1切割质粒DNA pBR322的能力。结果表明:配合物C1、C2对3种癌细胞都有较好的抑制作用,但是C1更优于C2;配合物C1与小牛胸腺DNA作用是插入结合作用所致,能有效的将超螺旋DNA pBR322切割成缺刻型DNA。     

双乙酰二茂铁缩肼基二硫代甲酸甲酯Schiff碱的合成、晶体结构和生物活性(英文)

用双乙酰二茂铁和肼基二硫代甲酸甲酯为起始原料,制备了含二茂铁的Schiff碱配体[(CH3)SSCNHN=C(CH3)(C5H4)]2Fe.利用元素分析以及红外光谱和单晶X射线衍射分析了产物的组成、化学特征及晶体结构,并测定了其生物活性.结果表明,标题化合物对Ec9706食管癌细胞株具有适度的生长抑制活性.     

Microwave assisted synthesis of disubstituted benzyltin arylformylhydrazone complexes: anticancer activity and DNA‐binding properties

Eight disubstituted benzyltin complexes, i.e., {[R(O)C=N‐N=C (Me)COO]R'₂Sn(CH₃OH)}_n ( 1a and 2b ), {[R(O)C=N‐N=C (Me)COO]R'₂Sn(CH₃OH)}₂ ( 1b and 1d ) and {[R(O)C=N‐N=C (Me)COO]R'₂Sn}_n ( 1c , 2a , 2c , and 2d ) (R = C₄H₃O‐, C₄H₃S‐, p–t‐Bu‐C₆H₄‐ or p‐MeO‐C₆H₄‐; R' = o‐Cl‐C₆H₄CH₂‐ or o‐Me‐C₆H₄CH₂‐), were prepared from the reaction of arylformylhydrazine, pyruvic acid and disubstituted benzyltin dichloride with microwave irradiation. All complexes were characterized by FT‐IR spectroscopy, ¹H, ¹³C and ¹¹⁹Sn NMR spectroscopy, HRMS, elemental analysis, X‐ray single‐crystal diffraction and TGA. The in vitro antitumour activities of all complexes were evaluated by an MTT assay against three human cancer cell lines (NCI‐H460, HepG2, and MCF7). 2b exhibited strong antitumour activity on HepG2 cells and was expected to be a suitable platform for further chemical optimization to develop as anticancer therapeutics. The DNA binding of 2b was studied by UV–visible absorption spectrometry, fluorescence competitive assays, viscosity measurements and gel electrophoresis. Molecular docking was used to predict the binding between 2b and DNA, and the results show that 2b can become embedded in the double helix of DNA and cleave DNA.     

5-(3-吡啶基)-2-芳氧乙酰胺基-1,3,4-噻二唑的合成、晶体结构及生物活性

吡啶作为苯环的生物等排体常被用作分子设计的有效基团[1,2],含吡啶类农药已成为近20多年来新农药创制研究的热点领域之一。1,3,4-噻二唑衍生物具有杀虫、杀菌、除草、调节植物生长以及药物活性等多种功效[3-9],因而该类化合物的研究迄今仍方兴未艾。本文根据活性亚结构连接法,     

Syntheses,crystal structures and antibacterial activities of two new Mn(II) complexes based on triaryltriazoles

Two new Mn(II) complexes, trans-[Mn(L1-L2)₂(NCS)₂] (1–2) with triaryltriazole (1, L1 = 3-(p-bromophenyl)-4-phenyl-5-(2-pyridyl)-1,2,4-triazole; 2, L2 = 3,4-bis(p-methylphenyl)-5-(2-pyridyl)-1,2,4-triazole), have been synthesized and structurally characterized by elemental analysis, FT-IR, ESI-MS, and single-crystal X-ray crystallography. Crystallographic studies revealed that both 1 and 2 contain a distorted octahedral [MnN₆] core with two trans-disposed NCS^? ions. The L1 ligand, 1 and 2, together with four known homologous Mn(II) complexes, trans-[Mn(L3-L6)₂(NCS)₂] (3–6) (3, L3 = 3-(p-methoxyphenyl)-4-(p-chlorophenyl)-5-(2-pyridyl)-1,2,4-triazole; 4, L4 = 3-(p-methoxyphenyl)-4-(p-bromophenyl)-5-(2-pyridyl)-1,2,4-triazole; 5, L5 = 3-(p-chlorophenyl)-4-(p-methylphenyl)-5-(2-pyridyl)-1,2,4-triazole; 6, L6 = 3,5-bis(2-pyridyl)-4-(p-methylphenyl)-1,2,4-triazole), were tested in vitro for their antibacterial activities against two Gram-positive bacterial strains and two Gram-negative bacterial strains by the MTT method. The results indicate that 1 exhibited better activity than Penicillin and Kanamycin against Pseudomonas aeruginosa and also better than its free L1 ligand.     

基于酰腙配体的双锡核二(2,4-二氯苄基)锡配合物的合成、结构及生物活性

二(2,4-二氯苄基)二氯化锡分别与对甲氧基苯甲酰肼缩2-丁酮酸或2-噻吩酰肼缩2-丁酮酸酸反应,合成了两个二(2,4-二氯苄基)锡配合物(C1、C2),通过傅里叶变换红外光谱仪(FTIR)、核磁共振波谱仪(NMR)、高分辨质谱仪(HRMS)以及X射线单晶衍射(SCXRD)等表征了配合物结构。 两个配合物分子均为双锡核分子,以Sn₂O₂四元环为中心对称,且锡原子与配位原子形成七配位畸变五角双锥构型。 配合物C1、C2在空气氛围,120 ℃以下可稳定存在。 配合物C1、C2对人肺癌细胞(NCI-H460)、人肝癌细胞(HepG2)和人乳腺癌细胞(MCF7)均有较好的抑制作用,配合物C1略优于C2。 配合物C1、C2通过插入结合方式与小牛胸腺DNA相互作用,并且配合物C1与DNA的作用略强于C2。     

水杨醛缩2-芴胺席夫碱的合成、晶体结构及生物活性

芴在煤焦油中的含量为1%～2%,全国每年可从中提取1.4万吨芴.芴是一种带有荧光的片状化合物,作为一种新型的发光材料主要用于制备芴基金属化合物、有机光导体、树脂、染料、Ziegler-Natta催化剂的给电子体等.     

Syntheses,characterization, and crystal structures of ruthenium(II)/(III) complexes with tridentate salicylaldiminato ligands

Treatment of [Ru(PPh₃)₃Cl₂] with one equivalent of tridentate Schiff base 2-[(2-dimethylamino-ethylimino)-methyl]-phenol (HL) in the presence of triethylamine afforded a ruthenium(III) complex [RuCl₃(κ²-N,N-NH₂CH₂CH₂NMe₂)(PPh₃)] as a result of decomposition of HL. Interaction of HL and one equivalent of [RuHCl(CO)(PPh₃)₃], [Ru(CO)₂Cl₂] or [Ru(tht)₄Cl₂] (tht = tetrahydrothiophene) under different conditions led to isolation of the corresponding ruthenium(II) complexes [RuCl(κ³-N,N,O-L)(CO)(PPh₃)] (2), [RuCl(κ³-N,N,O-L)(CO)₂] (3), and a ruthenium(III) complex [RuCl₂(κ³-N,N,O-L)(tht)] (4), respectively. Molecular structures of 1·CH₂Cl₂, 2·CH₂Cl₂, 3 and 4 have been determined by single-crystal X-ray diffraction.     

2-苯基-4-硒唑甲酸过渡金属配合物的合成、结构及生物活性研究

合成了2-苯基-4-硒唑甲酸配体(HL)和相应的6个过渡金属配合物[ML2(H2O)2](M=Co,Ni,Cu,Cd)1～4,[ZnL2](5),[CuL2(py)2](6).用元素分析、红外光谱、热重分析等表征手段确定了配合物的组成;用单晶X射线衍射测定了配合物3和6的结构;用溴化乙锭荧光探针初步研究了它们与DNA作用的强度和模式;考察了配体和配合物对大肠埃氏杆菌(E.coliJM109)、大肠杆菌(E.coli,DH5α)、表皮葡萄球菌(S.epidermidis)、金黄色葡萄球菌(S.aureus)、鲍曼不动杆菌(baumanii)、草绿色链球菌(S.viridans)6种细菌的抗菌活性及对正常细胞293T和肿瘤细胞RAW264.72的体外增殖抑制作用.     

溴钼环卡宾配合物的合成及结构

本文以三羰基戊二烯基钼负离子锂盐代替钠盐,成功地制得了溴钼环卡宾配合物。用X射线衍射测定了其晶体,晶体属正交晶系,空间群P2~12~12~1,晶体学数据:a=0.8600(2),b=1.4775(3),c=1.9900(7)nm;V=2.529nm^3,Z=8,D~x=1.93g.cm^-^3;μ=41.3cm^-^1,F(000)=1424。偏差因子R=0.055,R~w=0.060。     

Syntheses,crystal structures and thermal analyses of two new ionic complexes based on 3,4-diamino-1,2,4-triazole

Two new ionic complexes, (DATr)₂[Li₂(TNR)₂·2H₂O]·2H₂O (1) and (DATr)[Zn(DATr)Cl₃] (2), were synthesized by using 3,4-diamino-1,2,4-triazole (DATr) as outer cation. X-ray single-crystal diffraction analysis revealed that the two complexes crystallize in triclinic and orthorhombic crystal systems, respectively. Differential scanning calorimetry was applied to assess the thermal decomposition behavior and kinetic parameters of decomposition were studied by using Kissinger’s and Ozawa–Doyle’s methods. Furthermore, the critical temperature of thermal explosion and parameters of thermodynamics were obtained.     

Organotin complexes of pyruvic acid thiosemicarbazone: Synthesis,crystal structures and antiproliferative activity of neutral and cationic diorganotin complexes

The synthesis and spectral characterization of novel neutral and cationic organotin complexes with pyruvic acid thiosemicarbazone, H₂pt (1), [SnPh₂(pt)] (2), [SnMe₂(Hpt)(H₂O)]Cl (3) and [SnPh₂(Hpt)(H₂O)]Cl (4) are reported. The crystal structure of the complexes [SnPh₂(pt)] (2) and [SnMe₂(Hpt)(H₂O)]Cl (3) have been solved by single-crystal X-ray diffraction. The crystal structure of complex 2 showed that the ligand is doubly deprotonated at the oxygen and amide nitrogen atoms and is coordinated to the SnPh₂ fragment via two five-membered chelate rings. The monomers of 2 are linked through intermolecular hydrogen bonds of C−H–O type and through π−π intermolecular interactions. The crystal structure of [SnMe₂(Hpt)(H₂O)]Cl (3) showed that the ligand is mono-deprotonated at the oxygen atom and is coordinated to the SnMe₂ fragment via two five-membered chelate rings. The counter ion chloride is participated in intermolecular hydrogen bonds. An extended network of intermolecular hydrogen bonds leads to aggregation and a supramolecular assembly. The IR and NMR spectroscopic data of the complexes are reported. The in vitro cytotoxic activity has been evaluated against the cells of three human cancer cell lines: MCF-7 (human breast cancer cell line), T-24 (bladder cancer cell line), A-549(non-small cell lung carcinoma) and a mouse L-929 (a fibroblast-like cell line cloned from strain L). The most active of all was found the diorganotin complex 2. The cytotoxic activity shown by these compounds against all these cancer cell lines indicates that coupling of 1 with R₂Sn(IV) metal center result in metallic complexes with important biological properties and remarkable cytotoxic activity, since they are display IC₅₀ values in a μM range the same or better to that of the antitumor drug cisplatin. Compound 2 is considered as agent with potential antitumor activity, and can therefore be candidate for further stages of screening in vitro and/or in vivo.